Market Chameleon (Mon, 9-Mar 10:34 AM)
uniQure Faces FDA Setback on AMT-130 for Huntington’s Disease—What’s Next for the Program?
Market Chameleon (Mon, 2-Mar 7:09 AM)
QURE Pre-Earnings History Points to a Sharp Rally
Market Chameleon (Tue, 24-Feb 11:00 AM)
FDA Meeting Scheduled Could Accelerate Approval Path for uniQure’s Huntington’s Disease Gene Therapy
Market Chameleon (Fri, 9-Jan 7:28 AM)
